Eli Lilly discovers, develops, manufactures, and sells pharmaceuticals globally, with a significant presence in the United States, Europe, China, and Japan. The company operates across multiple therapeutic areas, including diabetes and obesity treatments (such as insulin formulations and newer agents like Mounjaro), cancer therapies targeting various tumor types, immunology medications, and drugs for migraine prevention and Alzheimer's disease. The firm maintains numerous partnerships and licensing agreements with other pharmaceutical and biotechnology companies to expand its product pipeline and development capabilities.

entry readiness 7 · NOT READY · exit proximity 38

Value area 1,102.96–1,237.80 · 1% of 120d volume overhead · clean runway